Literature DB >> 20306158

Heterogeneity of mitochondrial membrane potential: a novel tool to isolate and identify cancer stem cells from a tumor mass?

Xiao-Qun Ye1, Guang-Hui Wang, Gui-Jun Huang, Xiu-Wu Bian, Gui-Sheng Qian, Shi-Cang Yu.   

Abstract

It is believed that cancer stem cells (CSCs) are precursors for the formation, development, and recurrence of malignant tumors. However, it has proven difficult to isolate and enrich these rare, undifferentiated cells from heterogeneous tumor masses. With some existing reports and preliminary results in mind, we hypothesized that the mitochondrial membrane potential within a tumor mass was heterogeneous and could be used as a tool to isolate and enrich CSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20306158     DOI: 10.1007/s12015-010-9122-9

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  61 in total

1.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth.

Authors:  Sébastien Bonnet; Stephen L Archer; Joan Allalunis-Turner; Alois Haromy; Christian Beaulieu; Richard Thompson; Christopher T Lee; Gary D Lopaschuk; Lakshmi Puttagunta; Sandra Bonnet; Gwyneth Harry; Kyoko Hashimoto; Christopher J Porter; Miguel A Andrade; Bernard Thebaud; Evangelos D Michelakis
Journal:  Cancer Cell       Date:  2007-01       Impact factor: 31.743

Review 2.  Mitochondria in stem cells.

Authors:  Thomas Lonergan; Barry Bavister; Carol Brenner
Journal:  Mitochondrion       Date:  2007-05-23       Impact factor: 4.160

Review 3.  The relationship between pluripotency and mitochondrial DNA proliferation during early embryo development and embryonic stem cell differentiation.

Authors:  J M Facucho-Oliveira; J C St John
Journal:  Stem Cell Rev Rep       Date:  2009-04-03       Impact factor: 5.739

4.  Induction of osteoprogenitor cell differentiation in rat marrow stroma increases mitochondrial retention of rhodamine 123 in stromal cells.

Authors:  B Y Klein; I Gal; Z Hartshtark; D Segal
Journal:  J Cell Biochem       Date:  1993-11       Impact factor: 4.429

5.  Newborn neurons acquire high levels of reactive oxygen species and increased mitochondrial proteins upon differentiation from progenitors.

Authors:  Marina Tsatmali; Elisabeth C Walcott; Kathryn L Crossin
Journal:  Brain Res       Date:  2005-04-08       Impact factor: 3.252

6.  Mitochondrial remodeling in differentiating neuroblasts.

Authors:  Vladimir Voccoli; Laura Colombaioni
Journal:  Brain Res       Date:  2008-11-19       Impact factor: 3.252

7.  Opposing effects on mitochondrial membrane potential by malonate and levamisole, whose effect on cell-mediated mineralization is antagonistic.

Authors:  B Y Klein; I Gal; M Libergal; H Ben-Bassat
Journal:  J Cell Biochem       Date:  1996-01       Impact factor: 4.429

8.  Resistance to cytotoxic chemotherapy-induced apoptosis in side population cells of human oral squamous cell carcinoma cell line Ho-1-N-1.

Authors:  Tetsuo Yajima; Hiromi Ochiai; Takeshi Uchiyama; Nobuo Takano; Takahiko Shibahara; Toshifumi Azuma
Journal:  Int J Oncol       Date:  2009-08       Impact factor: 5.650

9.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

10.  Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.

Authors:  Maria M Ho; Alvin V Ng; Stephen Lam; Jaclyn Y Hung
Journal:  Cancer Res       Date:  2007-05-15       Impact factor: 12.701

View more
  19 in total

1.  Mitaplatin increases sensitivity of tumor cells to cisplatin by inducing mitochondrial dysfunction.

Authors:  Xue Xue; Song You; Qiang Zhang; Yan Wu; Guo-Zhang Zou; Paul C Wang; Yu-Liang Zhao; Yan Xu; Lee Jia; Xiaoning Zhang; Xing-Jie Liang
Journal:  Mol Pharm       Date:  2012-02-13       Impact factor: 4.939

2.  Quantitative Imaging of Morphometric and Metabolic Signatures Reveals Heterogeneity in Drug Response of Three-Dimensional Mammary Tumor Spheroids.

Authors:  V Krishnan Ramanujan
Journal:  Mol Imaging Biol       Date:  2019-06       Impact factor: 3.488

3.  Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects metabolic reprogramming and effectively inhibits cancer stem cells in Taxol(®)-resistant ovarian cancer.

Authors:  Yao-An Shen; Wai-Hou Li; Po-Hung Chen; Chun-Lin He; Yen-Hou Chang; Chi-Mu Chuang
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

Review 4.  Can nanomedicines kill cancer stem cells?

Authors:  Yi Zhao; Daria Y Alakhova; Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

5.  Mitochondrial metabolism directs stemness and differentiation in P19 embryonal carcinoma stem cells.

Authors:  I Vega-Naredo; R Loureiro; K A Mesquita; I A Barbosa; L C Tavares; A F Branco; J R Erickson; J Holy; E L Perkins; R A Carvalho; P J Oliveira
Journal:  Cell Death Differ       Date:  2014-05-16       Impact factor: 15.828

Review 6.  Targeting cancer stem cells from a metabolic perspective.

Authors:  Yao-An Shen; Siao-Cian Pan; I Chu; Ruo-Yun Lai; Yau-Huei Wei
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-26

Review 7.  Strategies for isolating and enriching cancer stem cells: well begun is half done.

Authors:  Jiang-Jie Duan; Wen Qiu; Sen-Lin Xu; Bin Wang; Xian-Zong Ye; Yi-Fang Ping; Xia Zhang; Xiu-Wu Bian; Shi-Cang Yu
Journal:  Stem Cells Dev       Date:  2013-05-09       Impact factor: 3.272

8.  Peptide nucleic acids targeting mitochondria enhances sensitivity of lung cancer cells to chemotherapy.

Authors:  Sheng-Song Chen; Xiao-Yun Tu; Li-Xia Xie; Lv-Ping Xiong; Juan Song; Xiao-Qun Ye
Journal:  Am J Transl Res       Date:  2018-09-15       Impact factor: 4.060

9.  Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.

Authors:  Yao-An Shen; Chia-Yu Wang; Yi-Tao Hsieh; Yann-Jang Chen; Yau-Huei Wei
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

10.  Hypoxic and Reoxygenated Microenvironment: Stemness and Differentiation State in Glioblastoma.

Authors:  Mariana Maier Gaelzer; Mariana Silva Dos Santos; Bárbara Paranhos Coelho; Alice Hoffman de Quadros; Fabrício Simão; Vanina Usach; Fátima Costa Rodrigues Guma; Patrícia Setton-Avruj; Guido Lenz; Christianne G Salbego
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.